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Background: The understanding of physiopathology and cognitive impairments in mood
disorders requires finding objective markers. Mood disorders have often been linked to
hypometabolism in the prefrontal dorsolateral cortex, and to GABAergic and glutamater-
gic neurotransmission dysfunction.The present study aimed to discover whether saccadic
tasks (involving DPLFC activity), and cortical excitability (involving GABA/Glutamate neu-
rotransmission) could provide neuropsychophysical markers for mood disorders, and/or
of its phases, in patients with rapid cycling bipolar disorders (rcBD). Methods: Two rcBD
patients were followed for a cycle, and were compared to nine healthy controls. A sac-
cade task, mixing prosaccades, antisaccades, and nosaccades, and an evaluation of cortical
excitability using transcranial magnetic stimulation were performed. Results:We observed
a deficit in antisaccade in patients independently of thymic phase, and in nosaccade in the
manic phase only. Cortical excitability data revealed global intracortical deficits in all phases,
switching according to cerebral hemisphere and thymic phase. Conclusion: Specific pat-
terns of performance in saccade tasks and cortical excitability could characterize mood
disorders (trait-markers) and its phases (state-markers). Moreover, a functional relationship
between oculometric performance and cortical excitability is discussed.
Keywords:TMS, saccade, cortical excitability, paired-pulse, inhibition/facilitation, GABA/glutamate
INTRODUCTION
Affective disorders are the most disabling of neuropsychiatric
conditions, and one of the four leading causes of disability [World
Health Organization (WHO), 2003]. Acquiring a better under-
standing of the physiopathology and cognitive impairments in
mood disorders requires the finding of “objective” indicators of
the illness. In the present pilot study, we tested two tools: ocu-
lometry (saccadic tasks) and cortical excitability (via magnetic
transcranial stimulation of the motor cortex), using a particu-
lar clinical paradigm: the follow-up of two patients suffering from
rapid cycling bipolar disorders (rcBD). The experimental rationale
was as follows.
MOOD DISORDERS AND SACCADIC PERFORMANCE
Over the past three decades, there has been an increase in the
number of neuropsychophysical studies of saccadic performance
in psychiatric patient groups (Gooding and Basso, 2008). Much of
the impetus for the focus on saccadic eye movements in these pop-
ulations comes from the fact that saccades provide a non-invasive
yet accessible means of investigating psychomotor functioning
as well as higher-order cognitive processes and their underlying
neural mechanisms. Most of the studies have focused on schizo-
phrenia patients, using mainly the antisaccade (AS) task (Hallett,
1978). In AS, subjects have to inhibit a reflexive movement toward a
peripheral cue and to produce a voluntary saccade in the opposite
direction (mirror position). In this task, the variables of inter-
est are: saccade errors, also known as inhibition errors (saccades
toward the cue); and latencies (or saccadic reaction time, SRT)
for correct AS. Fukushima et al. (1988) showed increased pro-
portions of saccade errors during AS in schizophrenic patients, a
result replicated many times and associated with reduced metabo-
lism in the frontal lobes (McDowell et al., 2002) or reduced frontal
brain volumes (Fukushima et al., 1990a). In schizophrenia, AS
performance is one of several endophenotype candidates (Radant
et al., 2007). While the number of studies on eye movements and
patients with schizophrenia or schizophrenia-spectrum disorders
is huge, there is relatively little research on eye movements and
mood disorders. In early investigations of saccadic performance,
the latter type of patients were regarded primarily as psychiatric
control subjects and were mixed into a single group regardless
of their pathologies (bipolar or unipolar). Investigations of AS
performance in patients suffering from major depressive disorder
(MDD) indicate that mild or moderately depressed patients dis-
play normal rates of inhibition error saccades (Fukushima et al.,
1990b), while acutely ill, unmedicated depressive patients display
elevated saccade error rates (Harris et al., 2009) or increased AS
www.frontiersin.org January 2013 | Volume 3 | Article 112 | 1
Malsert et al. Saccade and cortical excitability in rcBD
latencies (Crevits et al.,2005). These findings suggest,on the whole,
that AS impairments in major depression may be state-related. A
better way to characterize the relationship between mood state
and saccadic performance is to examine bipolar patients switch-
ing between opposing depressive and manic phases. To date, there
have been few published reports concerning bipolar disorders and
saccadic performance, and only one (Gooding et al., 2004) has fol-
lowed bipolar patients. In Gooding et al. (2004), 33 schizophrenia
out-patients and 10 bipolar out-patients performed two saccadic
tasks (pro and AS) at two separate assessments, with an average
delay of 33 months. Results showed that schizophrenic patients
displayed high test-retest reliabilities in the AS task despite changes
in medication and clinical status. By contrast, bipolar patients did
not show temporal stability in their AS performance. It is, however,
worth noting that the symptomatic status of bipolar patients also
changed over time. At the time of their initial assessment, the clin-
ical status of bipolar patients was mixed; three were depressed,
two were euthymic, and five were hypomanic. At the time of
retest, nearly all patients (90%) were acutely symptomatic; six were
depressed, and three were hypomanic. These clinical switches from
test to retest might be the reason why AS performance was unsta-
ble between the two assessments. Unfortunately the authors did
not analyze intra-individual saccadic performance between illness
phases. Does saccadic performance change according to mood
phase? Therefore as far as we know, no study has compared sac-
cadic performance between depressive and manic phases. In this
study, we followed two patients with bipolar disorder during the
different phases of their illness using a mixed SPAN (Saccade Pro,
Anti, and No) task. Parallel measures of cortical excitability were
also carried out.
MOOD DISORDERS AND CORTICAL EXCITABILITY
The use of transcranial magnetic stimulation (TMS) as a non-
invasive method of inducing depolarization or hyperpolarization
in neurons allows researchers to study functioning and intercon-
nections of the brain. Applied to the motor cortex, the TMS
magnetic field provides an opportunity to evaluate not only cere-
bral functional activity but also neurochemical properties, because
the magnetic coil preferentially depolarizes horizontally oriented
axons in the cortex. These axons consist primarily of excitatory
(glutamatergic) and inhibitory (GABAergic) interneurons which
regulate local excitability via very short axons (Markram et al.,
2004; Kapogiannis and Wassermann, 2008). This technique gives
a global view, known as “cortical excitability,” of interneuron acti-
vation in the cerebral cortex, and consequently any possible deficit
in one of them. Cortical excitability measures consist of the study
of neuronal reactivity in terms of resting motor threshold (RMT),
baseline, intracortical inhibition (ICI)/facilitation (and sometimes
the cortical silent period) from the TMS pulse through amplitude
recordings of motor evoked potentials (MEP; see Materials and
Methods).
Mood disorders are reflected by impairment principally in
the prefrontal cortex, but their clinical presentation suggests that
motor deficits are associated with the pathology (Campbell and
MacQueen, 2006). Moreover, clinical scales include items on
motor retardation; it is thus coherent to evaluate motor excitabil-
ity as an indicator of the neurophysiopathology underlying mood
disorders. Samii et al. (1996) observed a decrease in post-exercise
facilitation in depressive vs. control subjects, corresponding to a
deficiency in cortical excitability. These results were confirmed
by Shajahan et al. (1999), who suggested that facilitation cor-
related with depression severity and recovered after remission,
corresponding to a state indicator. Cortical excitability measured
in each hemisphere can also be used to study interhemispheric
asymmetries. Indeed, several neuroimaging studies have suggested
that MDD correspond to a disturbance in cortical activity with
lower left dorsolateral prefrontal cortex (DLPFC) or higher right
DLPFC activity (Baxter et al., 1989; Davidson and Meltzer-Brody,
1999). TMS studies showed a higher RMT in the left hemisphere
than in the right, in patients with MDD (Maeda et al., 2000). This
observation suggests stronger right cortex excitability in patients,
not noted in control subjects and consistent with neuroimaging.
Another study presented a decrease in right RMTs in patients,
corresponding to right-sided hypermetabolism (Bajbouj et al.,
2006a). In bipolar disorders, Levinson et al. (2007) demonstrated
a significant deficit in cortical inhibition in patients compared to
controls. As cortical inhibition processes are under the control of
GABAergic interneurons, these results show GABAergic pathway
involvement in depressive pathologies. The one longitudinal study
in bipolar patients was led by Chroni et al. (2008). The authors
evaluated the post-exercise facilitation of MEP in two patients
during different phases of rapid cycling depressive-manic disor-
der. Post-exercise MEP facilitation was significantly lower than
control values, but no differences were revealed between depressive
and manic phases, suggesting an invariable underlying association
between physiopathological psychiatric mechanisms and impaired
cortical excitability. To sum up, cortical excitability seems to be a
plausible biological correlate of disease and recovery in mood dis-
orders. So, we used this neurophysiological tool to characterize
rcBD and its phases, and to gain better understanding of some of
the possible deficits in saccadic performance.
PILOT STUDY AIMS
The research aimed to test whether saccadic performance and cor-
tical excitability measures could “sign” (be indicative of) rapid
cycling BD disease per se (trait-marker) and/or its phases (state-
marker), and if so, what the functional relationship between the
two types of markers might be.
MATERIALS AND METHODS
PARTICIPANTS
Patients
Two patients with rapid cycling bipolar disorders were followed
during the three illness phases. The diagnosis (Table 1) of rapid
cycling bipolar disorder was confirmed in accordance with DSM-
IV criteria by using the axis I disorders structured interview
(SCID-I, First, 1995), and the clinical severity of the phases of
the bipolar disorder were assessed using the Young Mania Rating
Scale (Young et al., 1978), and the Montgomery and Asberg Rating
Scale (Montgomery and Asberg, 1979).
The first patient, P1, is a 53-year-old right-handed man with a
significant severe thymic family history (including two suicides).
He experienced his first major mood episode (depressive polar-
ity) at the age of 38, and a very rapid form of mood fluctuations
progressively appeared, with 3 week hypomanic episodes and
Frontiers in Psychiatry | Neuropsychiatric Imaging and Stimulation January 2013 | Volume 3 | Article 112 | 2
Malsert et al. Saccade and cortical excitability in rcBD
Table 1 | Patient information.
P1 P2
Thymic phase Psychometric scores Medication Thymic phase Psychometric scores Medication
MADRS YMRS MADRS YMRS
Manic 8 20 LTG; CMZ Depressive 21 0 Li; VPA; VFX
Euthymic 12 4 LTG Euthymic 8 6 Li; VPA; VFX
Depressive 28 0 LTG; CMZ; S-Cit Manic 4 22 Li; VPA; OLZ
Abbreviations: MADRS, Montgomery and Asberg Depression Rating Scale; YMRS, Young Mania Rating Scale; LTG, lamotrigine; CMZ, cyamemazine; S-Cit,
escitalopram; Li, Lithium; VPA, divalproex; VFX, venlafaxine; OLZ, olanzapine.
1–4 week depressive episodes, with subsequent shortening of the
inter-critical periods and rapid onset of the acute phases.
The second patient, P2, is 60-year-old and right-handed, with a
family history of mood disorders, and has suffered from bipo-
lar disorder since he was 43, with a depressive polarity onset
and a rapid evolution toward the rapid cycling form, despite
various therapeutic strategies. Patients were evaluated during all
three illness phases (2.5 and 1.5 month intervals respectively):
Euthymic, Manic and Depressive phases. Test order and measures
were counterbalanced between patients.
Controls
Nine healthy control participants (four males, mean age
34± 11 years) without psychiatric history or medication com-
pleted the saccadic task and cortical excitability measures.
All participants met safety criteria for TMS as published by
Wassermann (1998) and gave their informed consent to the study
approved by the local ethical committee.
SACCADIC PERFORMANCE
Apparatus
A camera-based eye-tracker (EyeLink®1000 from SR Research with
EyeLink®CL software) with a temporal resolution of 500 Hz and
an accuracy of 0.02˚ was used, in the pupil-corneal reflection (P-
CR) tracking mode. A 3× 3 point calibration was completed and
a drift-correction was carried out every 10 trials. The eyetracker
detected saccades automatically as eye movements of a velocity
greater than 30˚/s and an acceleration greater than 8000˚/s2. For
further analyses we used saccade and fixation events computed by
the EyeLink software.
Stimuli
Stimuli were displayed on a 21′′ mean gray level (10 cd/m2 CIE
luminance) screen located 57 cm from participants. Screen res-
olution was 1024× 768 pixels, and the screen refresh rate 85 Hz.
Stimuli were numbers (“0” for the cue and “6” or “9” for the tar-
get) written in white (48 cd/m2 CIE luminance) inside a 1.2˚ white
ring, appearing peripherally at 10˚.
Procedure
The experimental paradigm is schematized in Figure 1. As men-
tioned above, it included three saccade types: Prosaccade (PS),
AS, and Nosaccade (NS). Patients were tested individually in a
darkened room. Head position was stabilized with a chin rest.
The saccadic task depends on the color of the central fixation
dot at the beginning of a trial, and uses a gaze contingent display.
Participants were told to make a PS if the color was green, an AS
if it was red, and a NS if it was blue. In PS condition, participants
had to look as quickly as possible at the peripheral cue location to
identify the number inside the target and to give an oral response
(“6” or “9”). In the AS condition, they had to look as quickly as
possible at the opposite side of the cue to identify the number
inside the target (which appeared only if participants gazed at the
correct location) and give an oral response (“6” or “9”).
Each trial began with a 500 ms presentation of a white central
fixation dot. The central fixation dot then became either green, or
red, or blue for 2 s. After this time, and only if the participant stared
at the fixation dot (±0.5˚ on the horizontal axis and ±1˚ on the
vertical axis) for 60 ms, a blank screen was displayed for 200 ms.
Then, a cue, always the number “0,” was flashed for 50 ms, at 10˚
peripherally (randomly on the left or right side of the screen).
The target appeared as soon as the participant gazed at the correct
position (depending on the saccade type; correct location ±1˚ on
the horizontal axis and ±2˚ on the vertical axis). Otherwise the
target appeared after a 2 s delay. The target was presented for 1 s,
on the same side as the cue in the PS condition, or on the opposite
side in the AS condition, or randomly on the left or right in the NS
condition. In the NS condition, participants had to keep their gaze
fixed on the centre of the screen. There was a break of 1 s between
two successive trials.
The identification task (to identify the number on the target)
was chosen to facilitate the understanding of the AS task and make
it more pleasant (Guyader et al., 2010). The order of assessments
in relation to mood phases was counterbalanced between patients.
Participants underwent a training session of 20 practice trials.
In the testing session, there were 80 trials: 16 for the NS condition,
32 for the PS condition, and 32 for the AS condition. The position
of the cue (left or right) and the number to be identified (6 or 9)
was randomly-distributed across conditions.
CORTICAL EXCITABILITY
We used a TMS MagPro X100 (Medtronic®) with a Magop-
tion to deliver paired-pulses. The coil is an eight-coil MCF-
B65. We recorded MEP to motor cortex stimulation with
three electrodes placed on the contralateral first dorsal inter-
osseous, and connected to an electrophysiological recording
system (NemusElectramed®; FDI). The cortical motor site which
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FIGURE 1 | Examples of trial sequences for the three saccadic conditions (red: AS, Blue: NS, and green: PS).
produced the largest MEP in the muscle for each hand was
located.
The cortical excitability protocol consisted of a set of measures
for each hemisphere. Firstly, we estimated the RMT. Then, we mea-
sured baseline motor potentials and four paired-pulse protocols
(at intervals of 2, 4, 10, and 15 ms). All subjects were tested with
the following protocol.
The RMT was determined as the minimum intensity that
evoked a peak-to-peak MEP superior to 50µV in at least five out
of 10 consecutive trials. RMT was expressed as a percentage of
maximal stimulator Intensity.
To measure the cortical excitability baseline, stimulations at
120% of the RMT were used, and peak-to-peak MEP amplitudes
(in µV) were recorded. Ten trials were performed and the five
largest were averaged.
The paired-pulse procedure for measuring intracortical
processes followed the one described in the literature (Kujirai
et al., 1993; Ziemann et al., 1996). All measurements were con-
ducted at rest with continuous MEP recording. An initial con-
ditioning stimulus which did not produce a MEP response was
set (at 80% RMT). A second stimulus (test stimulus) used a
consistent intensity (120% RMT) that would produce a MEP
response. Intracortical effect of conditioning stimulus (inhibitory
or facilitatory) is known to vary depending on inter stimulus
interval (ISI). This effect was calculated as a percentage of the
single pulse baseline, based on the average peak-to-peak MEP size.
Ten trials of data were recorded and the five largest responses
were averaged. Pharmacological studies (Kujirai et al., 1993; Zie-
mann et al., 1998) had shown that for ISIs inferior to 6 ms, the
conditioning stimulus inhibits the response to the test stimulus,
involving GABAA receptors, whereas for ISIs superior to 6 ms,
it facilitates responses with NMDA receptors involvement (glu-
tamatergic pathway). To test these two processes, inhibitory and
facilitatory, we used four ISI randomly-distributed conditions: 2,
4, 10, and 15 ms intervals.
RESULTS
SACCADIC PERFORMANCE
Saccadic performance is presented in Figure 2. We analyzed the
inhibition errors, i.e., the saccades toward the cue in the NS and
AS tasks. We also analyzed SRT for correct saccades for the two
tasks requiring saccade execution, AS and PS.
Analysis of inhibition errors
We reported the inhibition error rate for the first saccade after
cue onset. These errors only occurred for AS and NS, and are
summarized in Table 2 and Figure 2A.
Table 2 shows that the two patients presented performance
asymmetry related to the visual hemifield (cue position) in which
the cue was displayed. Irrespectively of mood phase and saccade
type, Patient 1 displayed weaker performance when the cue was
flashed in the right hemifield, with more erroneous inhibition sac-
cades in AS and NS tasks. This was also the case for Patient 2, except
for AS in his depressive phase.
As shown in Figure 2, in the AS task, mean percentages of sac-
cadic inhibition errors were very high compared to controls. In
the NS task, mean percentages of saccadic inhibition errors varied
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FIGURE 2 | Saccadic performance for each patient as a function of the two opposing illness phases (Depressive and Manic) and for controls (±CI). (A)
Mean percentages of saccadic inhibition errors in antisaccades (AS) and nosaccades (NS). (B) Mean SRT (in milliseconds) in prosaccades (PS).
Table 2 | Saccadic inhibition error rates as a function of saccadic task
(Antisaccade vs. Nosaccade), cue visual hemifield (Cue left vs. right),
and illness phase (Depressive, Manic, Euthymic) for each patient (P1,
P2) and for controls.
Task Antisaccade Nosaccade
Cue location Left (%) Right (%) Left (%) Right (%)
/ Controls 14 16 1 2
P1 Depressive 21 31 13 38
Euthymic 43 53 14 38
Manic 40 71 67 100
P2 Depressive 93 93 0 17
Euthymic 100 93 14 0
Manic 64 85 86 100
dramatically according to mood phase. The number of NS inhi-
bition errors was low in depressive as in euthymic periods (mean
17%) but very high in manic periods (88%). This pattern of results
was observed for each patient (Table 2). For AS and NS, the 95%
confidence interval (CI) for the percentage of inhibition errors
was calculated using the controls’ results. Both patients had per-
centages of inhibition errors for AS and NS in theirs mood phases
outside calculated CIs.
Analysis of correct saccades latencies
Because patients made a large number of AS errors, we carried
out a more specific study of correct latencies for PS (Figure 2B).
Patients displayed about 70% of correct PS saccades whatever their
mood period. The incorrect saccades were mainly due to the fact
that they made several hypometric (small) saccades to reach the
correct target location.
We ran an item analysis. For both patients, mean correct SRTs
were compared between the two illness phases. Paired t -test com-
parisons of mean SRTs showed a significant variation according
to mood phase. Saccade latencies were significantly shorter in the
manic phase compared to the depressive phase for each patient
[P1: 128 vs. 223 ms, t (20)= 3.18; p< 0.005; P2: 97 vs. 106 ms,
t (20)= 2.67, p< 0.05].
CORTICAL EXCITABILITY
Table 3 summarizes cortical excitability measures (RMT, base-
line, intracortical effects for short and long ISI) obtained in
the control group and for the two patients according to which
hemisphere was stimulated (Left vs. Right), and mood phase
for patients (Depressive, Euthymic, Manic). RMT and Baseline
results were given for information. These measures were neces-
sary to calculate modifications in baseline in the paired-pulse
condition according to temporal interval between pulses (ISI,
cf. Materials and Methods). We were therefore interested in
ICI and facilitation processes. Measures in ISI conditions are
expressed in baseline percentages, and are considered as mea-
sures of “intracortical excitability.” Result analysis focuses on
intracortical excitability.
As shown in Table 3, the two patients display intracortical
excitability changes compared to controls and according to mood
phases, with some between-subject variability. To simplify data
analysis and better understand the processes involved in these
changes, the performances of both patients were merged (the
two patients were considered as a group) and only the antagonist
mood phases were considered (Depressive vs. Manic. Reminder:
the euthymic phase was clinically not very clear).
As mentioned before, several studies have demonstrated that
for ISI of less than 6 ms, the conditioning stimulus inhibits the
test stimulus, whereas for ISI of between 6 and 100 ms, the
conditioning stimulation facilitates the test stimulation.
We looked firstly at whether we found this effect of short (2
and 4 ms) and long ISI (10 and 15 ms) in patients and controls.
Figure 3A represents mean baseline changes due to conditioning
stimulus. In line with the literature, ICI was observed for short
(2/4 ms) ISI, and facilitation (ICF) for long (10/15 ms) ISI (mean
ICI=−68%, mean ICF= 62%) in controls.
We calculated the 95% CI in percentage of baseline change for
long and short ISI calculated from the controls’ data. Patient’s
results were compared to the calculated CI for long and short ISI.
The pattern of excitability was reduced in patients compared to
controls whatever their mood phases. Reduction was clear for the
Patient 1 and for the Patient 2 for short ISI. For long ISI Patient P2
still had reduced percentage of baseline change in his manic phase.
These results mean that a reduced global pattern of intracortical
excitability could be indicative of the BD illness.
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Table 3 | Resting motor threshold (RMT), baseline MEP amplitude, and intracortical effects for short and long ISI for each hemisphere (LH/RH) in
controls and patients.
RMT (%) Baseline (µV) Short ISI (% change) Long ISI (% change)
LH RH LH RH LH RH LH RH
Controls 50 51 2118 1832 −61.6 −73.7 57.0 66.5
P1 Depressive 46 36 449 1441 −59.2 55.4 −22.6 −6.4
Euthymic 43 32 1660 1434 −22.8 −65.6 −11.6 −71.1
Manic 46 34 663 1352 −28.0 0.6 60.3 −1.8
P2 Depressive 48 44 1600 394 −59.6 −53.1 0.6 94.6
Euthymic 42 44 1520 1498 −26.5 −69.0 19.2 319
Manic 42 48 328 630 −56.1 −55.5 69.9 −38.6
FIGURE 3 | Cortical excitability. (A) Baseline modifications (%) in controls and patients (depressive/manic) according to Inter Stimulus Intervals (ISI
short/long). (B) Baseline modifications (%) in controls and patients (depressive/manic) according to stimulated hemisphere.
Figure 3B shows the global balance between inhibitory and
facilitatory processes in left and right hemisphere. No global
intracortical change was observed in controls (results did not
differ from zero), meaning that the control group presented a
good balance between intracortical excitability mechanisms and
hemispheres.
Interestingly, this was not the case for both patients who showed
a crossed interaction according to cerebral hemisphere. In the
depressive state, ICI seems to predominate in the left hemisphere,
and intracortical facilitation in the right hemisphere. The reverse
pattern of global intracortical excitability was observed in the
manic phase. Moreover, this interhemispheric asymmetry was
observed for each patient (Table 3).
DISCUSSION
Despite the consensus for impaired saccadic performance in psy-
chiatric disorders such as schizophrenia (Radant et al., 2007),
there is very little research on mood disorders and eye move-
ments. No study has aimed at investigating ocular movements
in relation to the depressive vs. manic phases in the same patient
(but, see Gooding et al., 2004). On the other hand, there is a rel-
ative consensus in literature that cortical excitability may be a
biological correlate of disease in mood disorders (Wassermann
et al., 2001; Bajbouj et al., 2006b; Levinson et al., 2010). Our
study associated these two techniques with two bipolar patients
to see if saccadic performance and cortical excitability measures
could serve as a trait-marker and/or state-markers, and what
the functional relationship between the two types of markers
might be.
SACCADIC PERFORMANCE
Despite differences in the two patients’ medication, clinical his-
tories (anamnesis) and intrinsic saccadic performances (Patient 1
displayed very rapid saccades), both presented two specific sac-
cadic performances. Compared to control participants, patients’
inhibition errors in the AS task were numerous, whatever their
mood phase, and this could possibly be a trait-marker of rapid
cycling BD. Compared to both themselves and controls, patients’
inhibition errors in the NS task were numerous in the manic phase,
suggesting that it could be a state-marker of the illness phase in
rapid cycling BD. What emerges from PS latencies significantly
distinguished the mood periods, with, notably, very short laten-
cies in manic phases. These results suggest that different types of
dysfunctions might well underlie inhibition errors in the manic
phase.
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CORTICAL EXCITABILITY
As for saccadic performance, we observed changes in patients’ cor-
tical excitability. Compared to controls and irrespective of mood
phase, patients displayed a lower “mean” intracortical excitabil-
ity (with a high degree of interhemispheric and phase variability
in measures), which could be a trait-marker of rapid cycling BD.
Compared to themselves, patients displayed a crossed asymmetry
of intracortical processes according to cerebral cortices and thymic
phases, which could be a state-marker of rapid cycling BD.
Cortical excitability depends on the balance between inhibitory
processes which suppress cortical activity, and excitatory ones
which stimulate it (Nakamura et al., 1997). We wondered what the
functional relationship between the imbalance of ICI and facilita-
tion observed in patients and their deficits in saccadic inhibitions
might be.
FUNCTIONAL RELATIONSHIPS BETWEEN OCULOMETRIC AND
INTRACORTICAL MARKERS?
Trait-markers
Both patients displayed a persistent inhibition deficit in AS, as well
as a lower mean intracortical excitability, with a high degree of
interhemispheric variability. Executing an appropriate AS depends
on inhibitory and excitatory control, brought into play in neural
circuitry involving a number of frontal structures (notably the
prefrontal dorsolateral cortex and the frontal eye field), and sub-
cortical structures (the basal ganglia, thalamus, superior collicu-
lus), and their accurate intra and interhemispheric management.
In other words, the execution of a correct AS requires the pos-
session of efficient frontal-striatal-thalamus-SC GABAergic and
glutamatergic networks (Munoz and Everling, 2004). This does
not seem to be the case for these patients, as can be seen from
their less efficient intracortical excitability (on average, compared
to controls), as well as the strong interhemispheric variability of
their inhibition (ICI) and facilitation (ICF) data. In short, the defi-
ciency of inhibition processes in the AS task observed in the two
patients, whatever their mood phase, could stem from the global
dysfunction of intracortical excitability processes observed in these
patients.
State-markers
The inhibition deficit in the NS task, observed during the manic
phase in both patients, could depend on a more specific mood
phase and hemisphere dependent GABAergic and/or Glutamater-
gic imbalance. Using a saccade paradigm similar to ours, Brown
et al. (2006) compared fMRI activation patterns for PS, AS, and
NS (called no-go trials) in humans. According to this research,
inhibitory control is more dependent on the right hemisphere
than on the left one. Patients’data obtained in our study are consis-
tent with this suggestion, with patients displaying fewer inhibition
errors when the cue was flashed in the left hemifield (Table 2). If
we observe mean right cortical excitability in patients, we can see
that our two patients did not present any intracortical facilitation
during manic phases (Figure 3B) but rather an ICI. The frontal-
SC neural circuitry controlling ocular saccades is intricate and
involves various subcortical structures as well as GABAergic and
glutamatergic pathways. We should, however, note the existence of
a direct top-down glutamatergic neural pathway from the frontal
cortex to fixation neurons in the superior colliculus (Olivier et al.,
2000; Munoz and Everling, 2004). So, if one assumes that the right
hemisphere plays a major role in saccadic control, and more espe-
cially via the direct glutamatergic pathway on fixation neurons in
the SC (fixation neuron activation must be maintained in the NS
task despite the absence of a fixation dot), the right hemisphere
glutamatergic deficit observed in patients during the manic phase
could underlie the poor NS performance of patients in the manic
phase.
LIMITATIONS
This pilot and princeps follow-up study aimed to see whether it
is possible to find psychophysical and neurophysiological trait-
and state-markers in mood disorders, using a particular clinical
paradigm (patients suffering from rapid cycling bipolar disorder)
and two experimental tools (saccadic tasks and cortical excitability
measured on the motor cortex via TMS pulses). The data obtained
appears interesting and relevant, indicating that these two tools
show changes in BD phases, with a possible functional coherence
between them. However, this research does have limits. One major
limit is the number of patients; the evaluation of only two patients
is insufficient to allow any definite conclusions to be drawn. It
should however, be noted that the prevalence of this psychiatric
illness is low, and it is therefore difficult to form a significant group
of rcBD patients. Secondly, patients were older than controls but
despite the limitations due to the difference in ages, the observation
of strong changes in NS performances and in cortical excitability
asymmetries depending on the mood phase suggests that these
effects are unrelated to age but to pathology. Moreover, it can be
even more surprising to observe intracortical processes switches
in older patients if we consider the reduction in cortical plasticity
demonstrated by Freitas et al. (2011).
Another limit concerns the interpretation of results. On the
one hand, GABAergic and glutamatergic functions were not
directly estimated but indirectly inferred from MEP resulting from
paired-pulse TMS applied to the motor cortex. On the other
hand, the cerebral circuitry underlying ocular movements is very
intricate and involves interacting GABAergic and glutamatergic
pathways. Therefore, explaining patients’ saccadic performance
by precise GABAergic and glutamatergic dysfunctions is, to say
the least, a “delicate” theoretical exercise. However, postulating
that an efficient saccadic control requires efficient GABAergic and
glutamatergic neurotransmission is “reasonable.”
LINKS WITH OTHER STUDIES
Several papers have tried to distinguish different processes in cog-
nitive and motor inhibition (Nigg, 2000; Friedman and Miyake,
2004; Fournet et al., 2007). In his paper, Nigg (2000) opposed
oculomotor inhibition (“intentional behavioral inhibition”) to
different kinds of cognitive inhibition (“intentional cognitive resis-
tance to interferences” or “intentional cognitive inhibition”). Our
results suggest that oculomotor inhibition may involve different
kinds of cognitive processes. As in the Stroop task, the AS task
involves “interference control for behavioral response” and this
type of control would thus be impaired in rapid cycling BD.
On the other hand, as in the classical No-go task, the NS task
www.frontiersin.org January 2013 | Volume 3 | Article 112 | 7
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involves “intentional motor inhibition” related to the suppres-
sion of motor response to distractors and this type of control
would thus be impaired in the manic phase of rapid cycling BD
throughout the DLPFC – Superior Colliculus – Frontal Eye Field
network dependent on inhibitory and excitatory control (Alexan-
der et al., 1990; Cummings, 1993). From this perspective, an
immuno-histochemical study by Olivier et al. (2000) presented
evidence for the presence of glutamatergic neurons in the cat
superior colliculus, and confirmed the existence of these neu-
rons in the rostral zone where SC fixation neurons SC project
contralaterally.
Swann et al. (2009) wrote that pathological impulsivity in
BD could be related to deficiencies in attention and response
inhibition in more severe illness courses, therefore inhibition
deficits could correspond to promising endophenotypes. Accord-
ing to Cherlyn et al. (2010), BD can be seen as complex disor-
ders in synaptic neurotransmission particularly involving Glu-
tamate and GABA neurotransmitters. Along with deficits in
glutamatergic neurotransmission, hyperactivity of GABAergic
neurotransmission is thought to be associated with schizophrenia
and mania, as evidenced by the psychotomimetic effects of GABAA
receptor agonists (Tamminga et al., 1978; Hoehn-Saric, 1983). Our
data are in agreement with these observations, more particularly
if we observe right hemisphere changes. Indeed, we observed an
association between NS inhibition errors in the manic phase and
deficits in glutamatergic communication in the right hemisphere,
which is the principal hemisphere for saccadic control.
To conclude, little is known about the categorization and under-
standing of mood disorders yet. In order to better understand the
pathological mechanisms of these psychiatric disorders, identi-
fication of different types of illness markers, from genetic and
chemical to neurophysiological and behavioral levels, appears
to be an essential research approach. This study seems to indi-
cate that oculometry (psychophysical) and cortical excitability
(neurophysiological) can provide useful and coherent markers of
bipolar disorders and their phases. However, these results need
confirmation on an important number of patients with rapid
cycling BD.
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